tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CRL is currently covered by 20 analysts with an average price target of $160.75. This is a potential upside of $23.85 (17.42%) from yesterday's end of day stock price of $136.9.
Charles River Laboratories's activity chart (see below) currently has 202 price targets and 201 ratings on display. The stock rating distribution of CRL is 48.48% BUY, 48.48% HOLD and 3.03% SELL.
Analysts average stock forecasts to be materialized ratio is 66.86% with an average time for these price targets to be met of 85.69 days.
Highest price target for CRL is $240, Lowest price target is $160, average price target is $214.
Most recent stock forecast was given by MATTHEW SYKES from GOLDMAN SACHS on 21-Mar-2025. First documented stock forecast 30-Oct-2014.
Currently out of the existing stock ratings of CRL, 32 are a BUY (48.48%), 32 are a HOLD (48.48%), 2 are a SELL (3.03%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$170
$14.45 (9.29%)
$190
14 days ago
(21-Mar-2025)
0/4 (0%)
$2.72 (1.63%)
Hold
$160
$4.45 (2.86%)
$166
1 months 15 days ago
(20-Feb-2025)
4/4 (100%)
$-5 (-3.03%)
40
Hold
$173
$17.45 (11.22%)
$190
1 months 15 days ago
(20-Feb-2025)
11/14 (78.57%)
$8 (4.85%)
67
Hold
$184
$28.45 (18.29%)
$205
1 months 30 days ago
(05-Feb-2025)
11/14 (78.57%)
$18.13 (10.93%)
55
Hold
$175
$19.45 (12.50%)
$205
2 months 1 days ago
(03-Feb-2025)
2/3 (66.67%)
$13.38 (8.28%)
24
What is CRL (Charles River Laboratories) average time for price targets to be met?
Which analyst has the current highest performing score on CRL (Charles River Laboratories) with a proven track record?
Which analyst has the most public recommendations on CRL (Charles River Laboratories)?
Which analyst is the currently most bullish on CRL (Charles River Laboratories)?
Which analyst is the currently most reserved on CRL (Charles River Laboratories)?
